Health Condition 1: null- patients who underwent PCI for multivessel coronary artery disease .
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All consecutive patients who underwent PCI for multivessel coronary artery disease in our hospital from April 2009 to April 2015 will be enrolled into the study as development set. Patients who undergo the same procedure from April 2015 to April 2017 will form the validation set.
Exclusion criteria
Exclusion criteria: Patients who developed PCI related complications will be ex¬cluded apart from those with inadequate data or inability to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the incidence of MACE in patients with multivessel coronary artery disease treated with PCI.Timepoint: To determine the incidence of MACE in patients with multivessel coronary artery disease treated with PCI. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To identify the risk factor profile for these patients and to compare it with the results of studies conducted elsewhere. 2.To estimate the cumulative risk rendered by individual angiographic and clinical risk factors and to develop a simple risk score model to predict MACE at 30days in patients with multivessel coronary artery disease. 3.To validate this risk model in a sample patient population of similar profile prospectively. Timepoint: 1.To identify the risk factor profile for these patients and to compare it with the results of studies conducted elsewhere. 2.To estimate the cumulative risk rendered by individual angiographic and clinical risk factors and to develop a simple risk score model to predict MACE at 30days in patients with multivessel coronary artery disease. 3.To validate this risk model in a sample patient population of similar profile prospectively. | — |
Countries
India
Contacts
The Madras Medical Mission Hospital